Iradimed Corp(IRMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 46.85 | EPS (ttm) | 1.79 | Insider Own | 34.85% | Shs Outstand | 12.8M | Perf Week | -4.42% |
| Market Cap | 1.07B | Forward P/E | 34.21 | EPS next Y | 16.09% | Insider Trans | -0.99% | Shs Float | 8.3M | Perf Month | -2.93% |
| Enterprise Value | 1.01B | PEG | 2.84 | EPS next Q | 0.55 | Inst Own | 61.75% | Short Float | 8.05% | Perf Quarter | -11.85% |
| Income | 0.02B | P/S | 12.43 | EPS this Y | 9.5% | Inst Trans | 1.98% | Short Ratio | 5.43 | Perf Half Y | 0.26% |
| Sales | 0.09B | P/B | 10.55 | EPS next 5Y | 12.05% | ROA | 20.82% | Short Interest | 0.67M | Perf YTD | -13.72% |
| Book/sh | 7.96 | P/C | 18.17 | EPS past 3/5Y | 19.88% 73.89% | ROE | 23.52% | 52W High | -22.22% ($107.90) | Perf Year | 5.73% |
| Cash/sh | 4.62 | P/FCF | 42.72 | Sales past 3/5Y | 16.28% 21.45% | ROIC | 22.66% | 52W Low | 11.37% ($75.36) | Perf 3Y | 106.85% |
| Dividend Est. | $0.77 (0.92%) | EV/EBITDA | 34.75 | EPS Y/Y TTM | 11.08% | Gross Margin | 75.86% | Volatility(W/M) | 2.15% 2.33% | Perf 5Y | 147.72% |
| Dividend TTM | 0.77 | EV/Sales | 11.75 | Sales Y/Y TTM | 11.21% | Oper. Margin | 31.92% | ATR (14) | 2 | Perf 10Y | 834.1% |
| Dividend Ex-Date | 2026/8/14 | Quick Ratio | 8.13 | EPS Q/Q | -9.87% | Profit Margin | 26.7% | RSI (14) | 37.3 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.46 | Sales Q/Q | 0.28% | SMA20 | -3.36% ($86.85) | Beta | 0.88 | Target Price | $118 |
| Payout | 38.88% | Debt/Eq | 0 | Earnings | 2026/10/30 | SMA50 | -2.28% ($85.89) | Rel Volume | 1.31 | Prev Close | $83.95 |
| Employees | 166 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 4.55% 0.57% | SMA200 | -9.49% ($92.73) | Avg Volume(3M) | 0.12M | Price | $83.93 |
| IPO | 2014/7/16 | Option/Short | Yes/Yes | Trades | 4134 | Volume | 161,647 | Change | -0.02% |
IRMD (Iradyamed) is a U.S. medical device company that specializes in the development, manufacturing, and sale of non-magnetic medical devices designed for safe use in magnetic resonance imaging (MRI) environments. The company supplies non-magnetic infusion pumps that enable intravenous delivery during MRI scans, as well as patient vital-sign monitoring systems. It has established a leading position in the niche market of MRI suites, where magnetic interference is a critical concern. Its primary customers are hospitals and acute-care medical facilities, and it sells its products in both the U.S. and international markets.
Over the past 1 year, roughly in the middle
22% below its 1-year high.
Traded more than usual. That is 131% of its average volume.
Next earnings report: October 30
1 days to go.
IRMD makes money exceptionally well
Of every $100 in sales, $31.92 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.5% this year.
Tap to view numbers
However, it looks expensive
For a company expected to earn $100 next year, you would pay $3,421. Peers typically go for $1,658. Compared with its own 5-year average, it is 22% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +147.7%. The S&P 500 did +69% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.92% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 61.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #41 of 142 in the industry
Based on market cap of $1B.
PRCT#38 Procept BioRobotics Corp $1B PER - 
AORT#39 Artivion Inc $1B PER - 
LMRI#40 Lumexa Imaging Holdings Inc $1B PER - IRMD#41 Iradimed Corp $1B PER 46.9 
CBLL#42 Ceribell Inc $1B PER - 
FAQ
What kind of company is IRMD?
IRMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of IRMD?
The market cap of IRMD is approximately $1.1B, ranking 2,530 within its sector.
Does IRMD pay dividends?
IRMD has a dividend yield of approximately 0.92%, with an annual dividend of $0.77.
What is the P/E ratio of IRMD?
IRMD has a P/E ratio of approximately 46.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for IRMD?
IRMD has recorded a 52-week high of $107.90 and a low of $75.36.
